SCHB 📈 Schwab U.S. Broad Market - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085241029 • Large Blend
SCHB: Stocks, U.S. Companies, Equities, Securities
The Schwab U.S. Broad Market ETF, listed on the NYSE ARCA under the ticker symbol SCHB, is designed to track the performance of a broad range of U.S. stocks. To achieve this, the fund primarily invests in stocks that are components of its underlying index, which comprises the largest 2,500 publicly traded U.S. companies with readily available pricing information. This approach ensures that the fund captures a significant portion of the U.S. equity market, providing investors with diversified exposure to large-cap, mid-cap, and small-cap stocks. By investing in such a wide array of companies, the fund aims to mirror the overall performance of the U.S. stock market, making it an attractive option for those seeking broad market coverage.
In terms of its investment strategy, the fund is required to allocate at least 90% of its net assets to stocks included in the index. This means that the majority of the fund's portfolio will be comprised of these index constituents, ensuring that the fund remains true to its objective of tracking the broad U.S. market. However, the fund also has the flexibility to invest up to 10% of its net assets in securities not included in the index. This allows the fund managers to make tactical adjustments to the portfolio, potentially taking advantage of opportunities in other areas of the market or managing risk. The fund's investment approach is straightforward, with a focus on providing investors with a low-cost, efficient way to gain exposure to the U.S. stock market.
From a structural perspective, the Schwab U.S. Broad Market ETF is a U.S.-domiciled exchange-traded fund (ETF) with the ISIN code US8085241029. It falls under the large blend ETF category, indicating that it is designed to track the performance of a broad market index with a focus on large-cap stocks, but also includes mid-cap and small-cap stocks to provide a comprehensive view of the U.S. market. The fund's website, http://www.schwabfunds.com, provides additional information on the fund's investment objective, strategy, and performance, as well as other details that may be of interest to potential investors.
Additional Sources for SCHB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
SCHB ETF Overview
Market Cap in USD | 33,718m |
Category | Large Blend |
TER | 0.03% |
IPO / Inception | 2009-11-03 |
SCHB ETF Ratings
Growth 5y | 79.8% |
Fundamental | - |
Dividend | 43.6% |
Rel. Strength Industry | -3.32 |
Analysts | - |
Fair Price Momentum | 23.53 USD |
Fair Price DCF | - |
SCHB Dividends
Dividend Yield 12m | 0.87% |
Yield on Cost 5y | 1.68% |
Annual Growth 5y | 2.31% |
Payout Consistency | 92.7% |
SCHB Growth Ratios
Growth Correlation 3m | 85.2% |
Growth Correlation 12m | 96.7% |
Growth Correlation 5y | 79.5% |
CAGR 5y | 14.06% |
CAGR/Mean DD 5y | 2.04 |
Sharpe Ratio 12m | 1.49 |
Alpha | -1.35 |
Beta | 1.04 |
Volatility | 24.65% |
Current Volume | 5173.1k |
Average Volume 20d | 3419.3k |
As of December 22, 2024, the stock is trading at USD 22.90 with a total of 5,173,100 shares traded.
Over the past week, the price has changed by -3.37%, over one month by -0.96%, over three months by +3.22% and over the past year by +23.78%.
Yes. Based on ValueRay Analyses, Schwab U.S. Broad Market (NYSE ARCA:SCHB) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 79.83 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SCHB as of December 2024 is 23.53. This means that SCHB is currently overvalued and has a potential downside of 2.75%.
Schwab U.S. Broad Market has no consensus analysts rating.
According to ValueRays Forecast Model, SCHB Schwab U.S. Broad Market will be worth about 26.2 in December 2025. The stock is currently trading at 22.90. This means that the stock has a potential upside of +14.41%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.2 | 14.4% |